Filing Details
- Accession Number:
- 0001181431-12-031702
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-05-22 17:58:43
- Reporting Period:
- 2012-05-21
- Filing Date:
- 2012-05-22
- Accepted Time:
- 2012-05-22 16:58:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1484478 | Furiex Pharmaceuticals Inc. | FURX | Pharmaceutical Preparations (2834) | 271197863 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1033409 | N Fredric Eshelman | C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-05-21 | 2,400 | $16.15 | 2,215,435 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 66,814 | Indirect | LLC |
Common Stock | 41,666 | Indirect | GRAT |
Common Stock | 140 | Indirect | Spouse |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (to buy) | $9.11 | 2020-06-17 | 131,751 | 131,751 | Indirect | |
Common Stock | Stock Options (to buy) | $13.16 | 2021-10-03 | 98,813 | 98,813 | Indirect |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2020-06-17 | 131,751 | 131,751 | Indirect |
2021-10-03 | 98,813 | 98,813 | Indirect |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $15.93 to $16.40. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The options were awarded on 6/17/2010 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's consulting relationship continues.
- The options were awarded on 10/3/2011 and vest over three years, with one-third of the options vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.